Search
for
Sort by
Research 721–750 of 1000+
- Guidelines for the management of androgenetic alopecia (2010)
- Current evaluation of amenorrhea
- Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Morphological Approach to Hair Disorders
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Epidemiology of hirsutism among women of reproductive age in the community: a simplified scoring system
- Short anagen syndrome
- WISP-1 induced by mechanical stress contributes to fibrosis and hypertrophy of the ligamentum flavum through Hedgehog-Gli1 signaling
- Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review
- Patterns of ovarian morphology in polycystic ovary syndrome: a study utilising magnetic resonance imaging
- Pregnancy and the Skin
- Circulatory Changes in Alopecia
- The bright side of fibroblasts: molecular signature and regenerative cues in major organs
- Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia
- Interventions for female pattern hair loss
- Androgens in women
- Therapeutic potential of bimatoprost for the treatment of eyebrow hypotrichosis
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- Stress and Psychoneuroimmunologic Factors in Dermatology
- Understanding and Addressing Hair Disorders in Transgender Individuals
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- PLASMA C19 STEROID SULPHATE LEVELS AND INDICES OF ANDROGEN BIOAVAILABILITY IN FEMALE PATTERN ANDROGENIC ALOPECIA
- Cutaneous Lesions in Systemic Lupus Erythematosus
- Defining Skin Fibroblastic Cell Types Beyond CD90
- Experimental and Clinical Pharmacology of<i>Ziziphus jujuba</i>Mills
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- Female pattern hair loss, sebum excretion and the end-organ response to androgens
- Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism*